Predicting HIV care costs using CD4 counts from clinical trials

Keyphrases

• CD4 Count 100%
• Clinical Trials 100%
• HIV Care 100%
• Health Care Costs 100%
• Darunavir 100%
• Protease Inhibitors 60%
• New Antiretrovirals 40%
• Overall Cost 40%
• HIV Research Network 40%
• Antiretroviral 20%
• Antiviral Drugs 20%
• HIV Patients 20%
• HIV Treatment 20%
• Antiretroviral Therapy 20%
• Cost Savings 20%
• Healthcare Settings 20%
• Patient Care 20%
• Primary Care 20%
• HIV Clinics 20%
• Antiretroviral Agents 20%
• Combination Treatment 20%
• Twice Daily 20%
• Ritonavir 20%
• Drug Costs 20%
• Net Savings 20%
• University of Alabama at Birmingham 20%
• Count Data 20%
• Type of Analysis 20%
• University of Alabama 20%
• Budget Impact 20%
• Cohort Data 20%
• Predicted Cost 20%

Nursing and Health Professions

• Human Immunodeficiency Virus 100%
• CD4 Lymphocyte Count 100%
• Darunavir 50%
• Proteinase Inhibitor 37%
• Health Care Cost 25%
• Hospital 12%
• Primary Medical Care 12%
• Patient Care 12%
• Low Drug Dose 12%
• Cost Control 12%
• Antiretrovirus Agent 12%
• Darunavir Plus Ritonavir 12%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Clinical Trial 100%
• Darunavir 50%
• Proteinase Inhibitor 37%
• Antiretrovirus Agent 12%
• Darunavir Plus Ritonavir 12%